483
Curia New Jersey, LLCFDA 483 - Curia New Jersey, LLC - September 21, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Curia New Jersey, LLC's Control Laboratory in Lebanon, NJ, identified a significant issue regarding the absence of critical testing equipment. The firm failed to follow established test procedures because X-Ray Powder Diffraction (XRPD) equipment, necessary for testing drug substance polymorphic forms at release and during stability, was not available on site. This indicates a serious deficiency in quality control and laboratory operations.
Open in Dashboard
ID · e17ac59c-b9aa-4b34-9ffb-99d238987c5a